Article Details

Hemogenyx to get Chinese patent for use of antibody in stem cell transplant | Seeking Alpha

Retrieved on: 2022-08-15 08:17:43

Tags for this article:

Click the tags to see associated articles and topics

Hemogenyx to get Chinese patent for use of antibody in stem cell transplant | Seeking Alpha. View article details on hiswai:

Excerpt

The London-based company said the notification was issued on July 20 and also covers composition of matter (a subset of sequences) of monoclonal ...

Article found on: seekingalpha.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up